Immix Biopharma Insider Filing: Jason Hsu Adds Option Position, No Sales
Rhea-AI Filing Summary
On 06/20/2025, Immix Biopharma (IMMX) director Jason Hsu filed a Form 4 disclosing a single insider transaction. The company issued Hsu a stock option covering 33,000 shares with a strike price of $2.24 per share. The option vests in twelve equal monthly installments from the grant date and expires on 06/20/2035, conditional on his continued service on the board.
After the award, Hsu reports total beneficial ownership of 4,861,913 common shares, broken down as: 893,000 shares held directly; 3,915,913 shares indirectly through Veritas Liberabit Vos, LLC; and 50,000 shares indirectly through Signature Collection Properties, LLC. No sales or dispositions occurred in this filing.
The incremental 33,000-share option grant represents less than 1 % of Hsu’s existing stake and does not materially alter the company’s capital structure. While the transaction reinforces management-shareholder alignment, its small size suggests limited immediate market impact.
Positive
- Director granted 33,000 options at $2.24, underscoring ongoing commitment and aligning incentives with shareholders.
Negative
- None.
Insights
TL;DR: Minor option grant; no shares sold; neutral for valuation.
The filing adds only 33 k options to a pre-existing 4.86 m-share position, implying negligible dilution. Absence of sales minimizes negative signalling risk, but the award size is too small to indicate strong insider conviction. Overall, I view the event as routine compensation with neutral implications for IMMX’s share price.
TL;DR: Standard board compensation; alignment intact; governance status unchanged.
The option vests monthly over one year, a conventional structure encouraging continued board engagement. Disclosure of indirect holdings through two LLCs maintains transparency. No red flags arise, yet the action is not large enough to be a positive catalyst. Governance outlook therefore remains unchanged.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 33,000 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Hsu disclaims beneficial ownership of the securities held by VERITAS LIBERABIT VOS, LLC, except to the extent of his pecuniary interest therein. Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Hsu disclaims beneficial ownership of the securities held by Signature Collection Properties, LLC, except to the extent of his pecuniary interest therein. The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.
